Stay informed with the latest litigation news. Explore now

IP Verse

Celator Pharmaceuticals competitive analysis

Latest publications and patents of Celator Pharmaceuticals New

Explore the latest publications and patents granted to Celator Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Celator Pharmaceuticals

EP3300601
Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative DisordersGranted And Under Opposition
EP2768484
Jul 24, 2019Lyophilized LiposomesRevoked
EP2120568
Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative DisordersRevoked

Latest patents of Celator Pharmaceuticals opposed by its competitors

Explore Celator Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3300601
Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders3
EP2768484
Jul 24, 2019Lyophilized Liposomes2
EP2120568
Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders2

Latest PTAB cases involving Celator Pharmaceuticals New

Discover the latest PTAB cases involving Celator Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Top competitors of Celator Pharmaceuticals

Top competitors of Celator Pharmaceuticals based on patent oppositions.